SCHEMBL6423706

SCHEMBL6423706

Cc1c(C(C(=O)O)C2CCCC2)c2cc(O)c(F)cc2n1C(=O)c1cccc(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.39
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HSD11B1 P28845 1/20 0.37
POLB P06746 1/20 0.37
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
IDO1 P14902 1/20 0.35
MGLL Q99685 1/20 0.35
LMNA P02545 1/20 0.35
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
SLC6A2 P23975 1/20 0.34
CHRNB4 P30926 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6423088 0.98 ALDH1A1 (0.37) L3MBTL1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL6425674 0.91 TDP1 (0.41) ALDH1A1KDM4EMEN1KMT2AHSD11B1
SCHEMBL6425613 0.90 AKR1C3 (0.41) MGLL
SCHEMBL6427504 0.89 USP2 (0.39) ALDH1A1KDM4EMEN1KMT2AHSD11B1
SCHEMBL6424919 0.89 MEN1 (0.37) MEN1KMT2AHSD11B1MGLL
SCHEMBL6423781 0.88 PDE2A (0.35) MGLLSLC6A3
SCHEMBL6424737 0.88 HSD11B1 (0.37) HSD11B1MGLLSLC6A4SLC6A3
SCHEMBL6423179 0.88 AKR1C3 (0.41) KDM4EMEN1KMT2ARAB9AMGLL
SCHEMBL6426037 0.87 MEN1 (0.37) ALDH1A1MEN1KMT2AHSD11B1MGLL
SCHEMBL6425963 0.86 PDE2A (0.35) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 L3MBTL1 4595/4885ALDH1A1 630/4885KDM4E 2209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.